Metraipolis › archive › dc_e8ddadffcdfa

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways — Europe PMC PMID:41019323

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41019323
DOI: 10.3389/fendo.2025.1630199
License (as archived): solo-consultazione
Archived: 2026-11-10T00:46:24.085Z
SHA-256 of the archived text: c00b0db30d612a8993052d06ebe6c2924da40e43b45f567ca9a648e91cd24d35
Stable URL of this page: https://metraipolis.com/documento/dc_e8ddadffcdfa

How to cite

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways — Europe PMC PMID:41019323 — Europe PMC (en), https://europepmc.org/article/MED/41019323 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8ddadffcdfa (Metraipolis archive dc_e8ddadffcdfa, sha256 c00b0db30d612a8993052d06ebe6c2924da40e43b45f567ca9a648e91cd24d35)

BibTeX

@misc{dce8ddadffcdfa,
  title = {A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways — Europe PMC PMID:41019323},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019323},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8ddadffcdfa; sha256 c00b0db30d612a8993052d06ebe6c2924da40e43b45f567ca9a648e91cd24d35},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019323. Agents can read the archived copy with the MCP tool read_document.